Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masaru Sato is active.

Publication


Featured researches published by Masaru Sato.


Journal of Gastroenterology and Hepatology | 2003

Rabeprazole treatment attenuated Helicobacter pylori-associated gastric mucosal lesion formation in Mongolian gerbils

Hidekazu Suzuki; Masaharu Miyazawa; Shoichi Nagahashi; Masaru Sato; Motoaki Bessho; Hiroshi Nagata; Soichiro Miura; Hiromasa Ishii

Background and Aim: Although rabeprazole (RPZ), a proton pump inhibitor, has been reported to have a bactericidal effect on Helicobacter pylori (H. pylori), no studies have been conducted regarding the effect of RPZ on gastric mucosal lesion formation caused by this bacterium. In the present study, we investigated the effect of RPZ on H. pylori‐associated gastric mucosal lesion formation.


Nihon Naika Gakkai Zasshi | 1979

PLEURAL EFFUSION-THE DIAGNOSTIC CLUE TO A PRIMARY HYPERPARATHYROIDISM PRESENTING AS CHRONIC RELAPSING PANCREATITIS AND NEPHROLITHIASIS

Daisuke Uematsu; Minoru Kanazawa; Tadashi Abe; Masaru Sato; Takeo Kawashiro; Hiromasa Ishii; Tetsuro Yokoyama

胸水貯留が診断の契機となり,膵石と膵のう胞を伴う慢性再発性膵炎および腎結石を合併した原発性副甲状腺機能亢進症を術前に診断し,縦隔内腺腫を摘出し得た1例を経験したので報告する.症例は35才の男.昭和51年11月より左季肋部痛が繰り返し出現した.昭和52年4月と10月に左側胸部痛を認め胸水を指摘され11月に入院した.胸水は血性滲出性でアミラーゼは30,200SUで血清,尿アミラーゼも高値を示した.アイソザイムはいずれも膵由来であつた. ERCPで膵石症と膵のう胞を認め慢性再発性膵炎と診断した.またIVPで右腎結石を認めた.血清Caは5.5mEq/l, Pは1.3mEq/lで%TRPは72%であつた.末梢血の副甲状腺ホルモン(c-assay)は0.1ng/mlであつたが最下甲状腺静脈血では4.25ng/mlで原発性副甲状腺機能亢進症と診断した.気縦隔法で,縦隔内腺腫が疑われた.胸骨上窩部切開により縦隔内副甲状腺腺腫を摘出した.本例においてはX線検査で骨病変は認められず,血清Caの上昇も軽度で,本症例の原発性副甲状腺機能亢進症は尿路結石群と考えられる.欧米では原発性副甲状腺機能尤進症に膵炎を合併した症例の報告はかなり見られるが本邦では現在まで8例の報告があるにすぎず,胸水を伴つた膵炎を合併した原発性副甲状腺機能亢進症としては本報告が第1例である.


Japanese Journal of Pharmacology | 1986

Biochemical and pharmacological analysis of 2-[(2-dimethylaminobenzyl)sulfinyl] benzimidazole (NC-1300), a new proton pump inhibitor

Susumu Okabe; Eiko Higaki; Tomoko Higuchi; Masaru Sato; Kaoru Hara


Archive | 1993

Benzimidazole derivatives as antimicrobal agent against Campylobacter pylon

Masaru Sato; Shigeru Souda


Archive | 1980

N-Acylcarnosine aluminum salt, its preparation, and a digestive ulcer remedy containing such salt

Susumu Okabe; Takashi Sonehara; Masaru Sato; Mitsuo Mazaki


Japanese Journal of Pharmacology | 1978

Fundamental studies on physiological and pharmacological actions of L-ascorbate 2-sulfate. V. On the hypolipidemic and antiatherosclerotic effects of L-ascorbate 2-sulfate in rabbits.

Eiichi Hayashi; Jun Yamada; Masaru Kunitomo; Mamoru Terada; Masaru Sato


Archive | 1998

Oxethazaine as antimicrobial agent

Masaru Sato; Makoto Hadano


Japanese Journal of Pharmacology | 1987

The Effect of trans-4-Guanidinomethylcyclohexanecarboxylic Acid p-tert-Butylphenyl Ester Hydrochloride (NCO-650) on Ascaris suum Antigen-Induced Bronchoconstriction in Dogs

Miwa Misawa; Kiyoteru Takenouchi; Masaru Sato; Saizo Yanaura


Japanese Journal of Pharmacology | 1987

The effects of chlorpheniramine and antiallergic drugs on Ascaris suum antigen-induced active cutaneous anaphylaxis in dogs.

Miwa Misawa; Kiyoteru Takenouchi; Masaru Sato; Saizo Yanaura


Archive | 1984

Novel aminoalcohol derivative and its preparation

Koichi Hashimoto; Toshiro Kamishiro; Mitsuo Mazaki; Naoya Morifuji; Masaru Sato; Atsuhiko Shinozaki

Collaboration


Dive into the Masaru Sato's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Susumu Okabe

Kyoto Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge